Mokosak Advisory Group’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$247K Hold
213
– – 0.05% 34
2026
Q2
$256K Buy
+213
New +$218K 0.06% 34
2026
Q1
– Sell
-213
Closed -$229K – 36
2025
Q4
$229K Buy
+213
New +$204K 0.06% 33

Other funds holding LLY

Mokosak Advisory Group's LLY Position: Q3 2026 in Review

Mokosak Advisory Group held its Eli Lilly (LLY) position steady in Q3 2026 at 213 shares worth $247K. The position accounts for 0.05% of the portfolio, ranked #34.

Mokosak Advisory Group first reported a position in LLY in Q4 2025 and has held it in 3 quarters since. The position peaked at $256K in Q2 2026. 1,995 funds tracked by Wall St. Rank hold LLY as of Q3 2026.

  • Mokosak Advisory Group held 213 shares of Eli Lilly worth $247K as of Q3 2026.
  • Mokosak Advisory Group left its Eli Lilly share count unchanged in Q3 2026.
  • Eli Lilly made up 0.05% of Mokosak Advisory Group's portfolio in Q3 2026, its #34 holding.
  • Mokosak Advisory Group first reported a position in Eli Lilly in Q4 2025 and has held it in 3 quarters since.
  • Mokosak Advisory Group's Eli Lilly position peaked at $256K in Q2 2026.
  • 1,995 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.

Based on Mokosak Advisory Group's 13F filing for Q3 2026, filed 20 Oct 2026.